Drawing for FRAGMENTIA-AI

USPTO serial 99551454

FRAGMENTIA-AI

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
CLONCH, ABIGAIL
Law office
TMO LAW OFFICE 114

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FRAGMENTIA-AI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eunyoung Lee

Eunyoung Lee MONAMI LAW GROUP PLLC816A Ambrose Ln.MANASSAS PARK, VA 20111United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for assisting in disease detection, monitoring, and treatment response evaluation; Downloadable computer software for data processing, feature extraction, and pattern recognition in medical and scientific research; Downloadable computer software using artificial intelligence (AI) for the analysis and interpretation of biological, genomic, and sequencing data; Recorded computer programs using artificial intelligence (AI) for the analysis and interpretation of biological, genomic, and sequencing dataACTIVE—
042Providing temporary use of on-line non-downloadable software for research and clinical data analysis; Scientific and technological services, namely, research, development, and data analytics in the field of genomics, oncology, and artificial intelligence; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for the analysis and interpretation of biological, genomic, and sequencing dataACTIVE—
044Medical services, namely, diagnostic testing and analysis services using artificial intelligence for detecting and monitoring disease, evaluating treatment response, and supporting clinical decision-makingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 18, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 20, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 20, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Apr 20, 2026CNSLSUSPENSION LETTER WRITTEN—
Apr 20, 2026DOCKASSIGNED TO EXAMINER—
Apr 14, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 16, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 16, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance